Drug maker Trevi Therapeutics (TRVI) is climbing 4.5% after investment bank Stifel raised its price target on the name to $12 ...

If you’re older, you may get a more severe infection than a younger person would, especially if you have an underlying chronic condition.” While vaccines don’t prevent older adults from getting ...